Immediate Impact
4 by Nobel laureates 57 standout
Citing Papers
Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside
2024 Standout
An “Inclisiran First” Strategy vs Usual Care in Patients With Atherosclerotic Cardiovascular Disease
2024 Standout
Works of Michael G. Collins being referenced
Effects of Renal Impairment on the Pharmacokinetics, Efficacy, and Safety of Inclisiran: An Analysis of the ORION-7 and ORION-1 Studies
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Michael G. Collins | 151 | 162 | 91 | 236 | 53 | 865 | |
| Ahmet Koç | 109 | 65 | 12 | 38 | 61 | 1.1k | |
| Johanna Eklund | 32 | 139 | 43 | 65 | 53 | 1.0k | |
| Osman Demir | 113 | 125 | 18 | 91 | 109 | 959 | |
| John S. Miller | 106 | 135 | 48 | 6 | 91 | 790 | |
| R. Higgins | 74 | 137 | 139 | 65 | 45 | 1.0k | |
| Bülent Turgut | 8 | 55 | 16 | 368 | 56 | 881 | |
| Jonas Egmose | 20 | 179 | 44 | 16 | 41 | 836 | |
| Daniel J. Wilson | 12 | 308 | 207 | 221 | 20 | 1.1k | |
| Kurt E. Schnier | 91 | 332 | 2 | 67 | 53 | 1.1k | |
| Dihua Li | 14 | 52 | 18 | 29 | 53 | 1.0k |
All Works
Login with ORCID to disown or claim papers
Loading papers...